Form 8-K - Current report:
SEC Accession No. 0001104659-25-121819
Filing Date
2025-12-17
Accepted
2025-12-17 07:05:40
Documents
15
Period of Report
2025-12-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2533462d1_8k.htm   iXBRL 8-K 27568
2 EXHIBIT 99.1 tm2533462d1_ex99-1.htm EX-99.1 23907
6 GRAPHIC tm2533462d1_ex99-1img001.jpg GRAPHIC 15783
7 GRAPHIC tm2533462d1_ex99-1img002.jpg GRAPHIC 10775
  Complete submission text file 0001104659-25-121819.txt   263189

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sgmt-20251217.xsd EX-101.SCH 3011
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgmt-20251217_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgmt-20251217_pre.xml EX-101.PRE 22356
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2533462d1_8k_htm.xml XML 3815
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

EIN.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41742 | Film No.: 251577234
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)